1 Organ Transplant Disruptor to Buy on the Dip
TransMedics (NASDAQ:TMDX) is an innovative biotechnology company that may well have the potential to disrupt the $11 billion organ transplant industry.
The company’s unique organ care system technology protects and monitors donor organs before they are transplanted into patients, resulting in improved organ health and outcomes. TransMedics also provides logistical services, including organ transportation through its fleet of 18 aircraft. » Read more about: 1 Organ Transplant Disruptor to Buy on the Dip »
Read More
Billionaires Are Loading Up on This Stock
When you look at search engine market share worldwide, no other comes close to Google (GOOGL)(GOOG). Over the past year, Google held a 92.% global market share, followed by Microsoft Bing with just 3.42%.
In spite of its dominance, Alphabet Inc., Google and YouTube’s parent company,
» Read more about: Billionaires Are Loading Up on This Stock »
Read More
Could Dell Rise 43.4%?
Dell has been around for more than 30 years and, in the past, focused mainly on manufacturing computers and other hardware, but recent acquisitions have broadened its offerings to include software, cloud-based services, data protection and more.
Given the uncertain economic climate, concerns loom over whether Dell can thrive? Will it prosper,
» Read more about: Could Dell Rise 43.4%? »
Read More
1 Stock Down 41% To Buy Now
» Read more about: 1 Stock Down 41% To Buy Now »
Read More
Is Tesla In Nose-Bleed Territory?
Tesla has had a scintillating run since Election Day with the stock rallying from the low $220 region all the way towards $350+ in a matter of days.
Having run so far so fast, what are the odds Tesla share price is set to correct soon? How high is too high for Tesla stock price?
» Read more about: Is Tesla In Nose-Bleed Territory? »
Read MoreThe Ivy
This AI-Powered Sports Stock That Just Scored Big, Is It a Buy?
Sportradar (NASDAQ:SRAD) should be on your radar for a stock to watch after soaring post earnings despite announcing mixed results for earnings versus revenue for Q4 of 2024.
The company surpassed consensus EPS estimates just once in the past four quarters but revenues have steadily increased and eclipsed consensus expectations.
» Read more about: This AI-Powered Sports Stock That Just Scored Big, Is It a Buy? »
Read MoreThe Spotlight
Spotlight: AI + Robotics = 4x Growth
Google. Apple. Amazon. Microsoft. They are all investing in AI but one company you probably have not heard about is Symbiotic, a warehousing automation firm that combines advanced robotics with artificial intelligence.
It’s one of those businesses that’s hard to wrap your head around at first but it’s been a huge hit on Wall Street.
» Read more about: Spotlight: AI + Robotics = 4x Growth »
Read MoreThe Daily
Universal Declares Regular and Special Cash Dividends
FORT LAUDERDALE, Fla., November 06, 2025–(BUSINESS WIRE)–Universal Insurance Holdings, Inc. (NYSE: UVE) (“Universal” or the “Company”) announced today that its Board of Directors has declared a regular quarterly cash dividend of 16 cents per share of common stock and a special cash dividend of 13 cents per share of common stock,
» Read more about: Universal Declares Regular and Special Cash Dividends »